Evidence map›Paper›PMID 31748751›Full record

ArticleNature protocols2019

High-throughput phenotyping with electronic medical record data using a common semi-supervised approach (PheCAP).

Yichi Zhang, Tianrun Cai, Sheng Yu, Kelly Cho, Chuan Hong, Jiehuan Sun, Jie Huang, Yuk-Lam Ho, Ashwin N Ananthakrishnan, Zongqi Xia and 18 more

Abstract read
In one paragraph

Article in Nature protocols, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Yichi Zhang *Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Tianrun Cai *Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, USA.
Sheng Yu *Center for Statistical Science, Tsinghua University, Beijing, China.
Kelly ChoDivision of Data Sciences, VA Boston Healthcare System, Boston, MA, USA.
Chuan HongDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Jiehuan SunDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Jie HuangDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, USA.
Yuk-Lam HoDivision of Data Sciences, VA Boston Healthcare System, Boston, MA, USA.ORCID http://orcid.org/0000-0003-3305-3830
Ashwin N AnanthakrishnanDepartment of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
Zongqi XiaDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-1500-2589
Stanley Y ShawDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Vivian GainerResearch Information Science and Computing, Partners Healthcare, Boston, MA, USA.
Victor CastroResearch Information Science and Computing, Partners Healthcare, Boston, MA, USA.
Nicholas LinkDivision of Data Sciences, VA Boston Healthcare System, Boston, MA, USA.
Jacqueline HonerlawDivision of Data Sciences, VA Boston Healthcare System, Boston, MA, USA.
Sicong HuangDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, USA.
David GagnonDivision of Data Sciences, VA Boston Healthcare System, Boston, MA, USA.
Elizabeth W KarlsonDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, USA.
Robert M PlengeDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, USA.
Peter SzolovitsDepartment of Electrical Engineering and Computer Science, MIT, Cambridge, MA, USA.
Guergana SavovaComputational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.
Susanne ChurchillDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Christopher O'DonnellDivision of Data Sciences, VA Boston Healthcare System, Boston, MA, USA.
Shawn N MurphyResearch Information Science and Computing, Partners Healthcare, Boston, MA, USA.
J Michael GazianoDivision of Data Sciences, VA Boston Healthcare System, Boston, MA, USA.
Isaac KohaneDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Tianxi CaiDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Katherine P LiaoDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, USA. kliao@bwh.harvard.edu.ORCID http://orcid.org/0000-0002-4797-3200

Funding

Informatics for Integrating Biology/ the Bedside (RMI)U54LM008748 · NLM · BRIGHAM AND WOMEN'S HOSPITAL · PI KOHANE, ISAAC S. · 2004 to 2013
$39.0M
MECHANISMS OF ARTHRITIC &DERMATOLOGY DISORDERST32AR007530 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Michael B. Brenner, Ellen M Gravallese · 1986 to 2026
$10.4M
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYticsP30AR072577 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Daniel Hal Solomon · 2017 to 2026
$9.8M
Leveraging electronic health records to optimize treatment selection and response in multiple sclerosisR01NS098023 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Zongqi Xia · 2016 to 2026
$4.6M
Developing i2b2 into a Health Innovation Platform for Clinical Decision Support in the Genomics EraR01HG009174 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI ARONSON, SAMUEL JEFFREY, MACRAE, CALUM A. · 2016 to 2019
$2.9M
Prediction of CVD Risk in VeteransI01CX001025 · VA · VETERANS HEALTH ADMINISTRATION · PI CHO, KELLY, WILSON, PETER WYMAN · 2014 to 2025
–
CSRD VA I01 CX001025NHGRI NIH HHS R01 HG009174NIAMS NIH HHS P30 AR072577NIAMS NIH HHS T32 AR007530NINDS NIH HHS R01 NS098023NLM NIH HHS U54 LM008748
6 · The paper itself

Abstract

Phenotypes are the foundation for clinical and genetic studies of disease risk and outcomes. The growth of biobanks linked to electronic medical record (EMR) data has both facilitated and increased the demand for efficient, accurate, and robust approaches for phenotyping millions of patients. Challenges to phenotyping with EMR data include variation in the accuracy of codes, as well as the high level of manual input required to identify features for the algorithm and to obtain gold standard labels. To address these challenges, we developed PheCAP, a high-throughput semi-supervised phenotyping pipeline. PheCAP begins with data from the EMR, including structured data and information extracted from the narrative notes using natural language processing (NLP). The standardized steps integrate automated procedures, which reduce the level of manual input, and machine learning approaches for algorithm training. PheCAP itself can be executed in 1-2 d if all data are available; however, the timing is largely dependent on the chart review stage, which typically requires at least 2 weeks. The final products of PheCAP include a phenotype algorithm, the probability of the phenotype for all patients, and a phenotype classification (yes or no).

Indexed as

Data AnalysisAlgorithmsData Interpretation, StatisticalElectronic Health RecordsHigh-Throughput Screening AssaysHumansMachine LearningNatural Language ProcessingPhenotype

Identifiers

PMID31748751
PMCPMC7323894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.